Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer

Cancer Genomics and Proteomics

Volumn 11, Issue 5, 2014, Pages 259-266

  Kim, Seung Tae ^a   Sohn, Insuk ^a   Do, In Gu ^a   Jang, Jiryeon ^a   Kim, Seok Hyung ^a   Jung, In Ho ^a,d   Park, Joon Oh ^a   Park, Young Suk ^a   Talasaz, Amirali ^b   Lee, Jeeyun ^a   Kim, Hee Cheol ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Sungkyunkwan University   (South Korea)

Author keywords

Cancer stem cells; CD133+; Interleukin 4; Surviving

Indexed keywords

ANTINEOPLASTIC AGENT; CD133 ANTIGEN; INTERLEUKIN 4; SURVIVIN; BIRC5 PROTEIN, HUMAN; GLYCOPROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TRANSCRIPTOME; TUMOR MARKER;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CCDC144B GENE; CCDC7 GENE; CDYL2 GENE; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CLEC4C GENE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE; GENE EXPRESSION PROFILING; GIMAP1 GENE; HEMICOLECTOMY; HIGH THROUGHPUT SCREENING; HUMAN; ICAM2 GENE; IL 4 GENE; IMMUNOHISTOCHEMISTRY; ISG15 GENE; LOC728875 GENE; LRRC2 GENE; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MGC27382 GENE; OSTF1 GENE; OVERALL SURVIVAL; PERINEURAL INVASION; PRB2 GENE; RECTUM ANTERIOR RESECTION; RNASE2 GENE; SALL3 GENE; TRANSCRIPTOMICS; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; UPREGULATION; ZEB1 GENE; ZIK1 GENE; AGED; CANCER STEM CELL; COLORECTAL TUMOR; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84908145670     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Surlin V, Ioana M and Plesea IE: Genetic patterns of metalloproteinases and their tissular inhibitors - clinicopathologic and prognostic significance in colorectal cancer. Rom J Morphol Embryol 52: 231-236, 2011.
3. Jemal A, Bray F, Center M.M., Ferlay J., Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
4. Comella P, Casaretti R, Sandomenico C., Avallone A and Franco L: Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence. Drugs 68: 949-961, 2008.
5. de Gramont A, Louvet C, Andre T., Tournigand C and Krulik M: A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD). Eur J Cancer 34: 619-626, 1998.
6. Capdevila J, Elez E, Peralta S., Macarulla T, Ramos FJ and Tabernero J: Oxaliplatin-based chemotherapy in the management of colorectal cancer. Expert Rev Anticancer Ther 8: 1223-1236, 2008.
7. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007.
8. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M., Todaro M, Peschle C and De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007.
9. Boman BM and Huang E: Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 26: 2828-2838, 2008.
10. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ and Clevers H: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007, 2007.
11. Singh SK, Hawkins C, Clarke I.D., Squire JA, Bayani J, Hide T, Henkelman R.M., Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004.
12. Zeki SS, Graham TA and Wright NA: Stem cells and their implications for colorectal cancer. Nat Rev Gastroenterol Hepatol 8: 90-100, 2011.
13. - metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120, 2008.
14. Todaro M, Lombardo Y, Francipane M.G., Alea MP, Cammareri P, Iovino F, Di Stefano AB, Di Bernardo C, Agrusa A, Condorelli G, Walczak H and Stassi G: Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ 15: 762-772, 2008.
15. Di Stefano AB, Iovino F, Lombardo Y., Eterno V, Hoger T, Dieli F., Stassi G and Todaro M: Survivin is regulated by interleukin-4 in colon cancer stem cells. J Cell Physiol 225: 555-561, 2010.
16. Bruns HA and Kaplan MH: The role of constitutively active Stat6 in leukemia and lymphoma. Crit Rev Oncol Hematol 57: 245-253, 2006.
17. Rothstein TL: Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res 10: 245-266, 2000.
18. Ansel KM, Djuretic I, Tanasa B and Rao A: Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24: 607-656, 2006.
19. Yang YL and Li XM: The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res 10: 169-177, 2000.
20. Mita AC, Mita MM, Nawrocki ST and Giles FJ: Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14: 5000-5005, 2008.
21. Pennati M, Folini M and Zaffaroni N: Targeting survivin in cancer therapy. Expert Opin Ther Targets 12: 463-476, 2008.
22. Li BH, Yang XZ, Li P.D., Yuan Q., Liu XH, Yuan J and Zhang WJ: IL-4/Stat6 activities correlate with apoptosis and metastasis in colon cancer cells. Biochem Biophys Res Commun 369: 554-560, 2008.
23. Porebska I, Sobanska E, Kosacka M and Jankowska R: Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer. Cancer Genomics Proteomics 7: 331-335, 2010.
24. Tanaka K, Iwamoto S, Gon G., Nohara T, Iwamoto M and Tanigawa N: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127-134, 2000.
25. Kato J, Kuwabara Y, Mitani M., Shinoda N, Sato A, Toyama T., Mitsui A, Nishiwaki T, Moriyama S, Kudo J and Fujii Y: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92-95, 2001.
26. Okada E, Murai Y, Matsui K., Isizawa S, Cheng C, Masuda M and Takano Y: Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163: 109-116, 2001.
27. Talasaz AH, Powell AA, Huber D.E., Berbee JG, Roh KH, Yu W, Xiao W., Davis MM, Pease RF, Mindrinos MN, Jeffrey SS and Davis RW: Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci USA 106: 3970-3975, 2009.
28. Ameri K, Luong R, Zhang H., Powell AA, Montgomery KD, Espinosa I, Bouley D.M., Harris AL and Jeffrey SS: Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br J Cancer 102: 561-569, 2010.
29. Cann GM, Gulzar ZG, Cooper S, Li R., Luo S, Tat M, Stuart S., Schroth G, Srinivas S, Ronaghi M, Brooks JD and Talasaz AH: mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS One 7: e49144, 2012.
30. Langmead B, Trapnell C, Pop M and Salzberg SL: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25, 2009.
31. Lee S, Seo CH, Lim B, Yang J.O., Oh J., Kim M, Lee S, Lee B., Kang C and Lee S: Accurate quantification of transcriptome from RNA-Seq data by effective length normalization. Nucleic Acids Res 39: e9, 2011.
32. Powell AA, Talasaz AH, Zhang H, Coram M.A., Reddy A., Deng G, Telli ML, Advani R.H., Carlson RW, Mollick JA, Sheth S, Kurian AW, Ford JM, Stockdale FE, Quake SR, Pease RF, Mindrinos MN, Bhanot G, Dairkee SH, Davis RW and Jeffrey SS: Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 7: e33788, 2012.
33. Calo V, Migliavacca M, Bazan V., Macaluso M, Buscemi M, Gebbia N and Russo A: STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197: 157-168, 2003.
34. Altieri DC: Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61-70, 2008.